Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 589

1.

Biochemical Changes in Erythrocytes as a Molecular Marker of Cell Damage during Long-Term Simvastatin Treatment.

Mikashinovich ZI, Belousova ES.

Bull Exp Biol Med. 2016 Aug;161(4):600-3. doi: 10.1007/s10517-016-3467-2. Epub 2016 Sep 3.

PMID:
27591878
2.

Large copy-number variations in patients with statin-associated myopathy affecting statin myopathy-related loci.

Stránecký V, Neřoldová M, Hodaňová K, Hartmannová H, Piherová L, Zemánková P, Přistoupilová A, Vrablík M, Adámková V, Kmoch S, Jirsa M.

Physiol Res. 2016 Aug 19. [Epub ahead of print]

3.

Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia.

Legge SE, Hamshere ML, Ripke S, Pardinas AF, Goldstein JI, Rees E, Richards AL, Leonenko G, Jorskog LF; Clozapine-Induced Agranulocytosis Consortium, Chambert KD, Collier DA, Genovese G, Giegling I, Holmans P, Jonasdottir A, Kirov G, McCarroll SA, MacCabe JH, Mantripragada K, Moran JL, Neale BM, Stefansson H, Rujescu D, Daly MJ, Sullivan PF, Owen MJ, O'Donovan MC, Walters JT.

Mol Psychiatry. 2016 Jul 12. doi: 10.1038/mp.2016.97. [Epub ahead of print]

PMID:
27400856
4.

The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia.

Sychev DA, Shuev GN, Chertovskih JV, Maksimova NR, Grachev AV, Syrkova OA.

Pharmgenomics Pers Med. 2016 May 25;9:59-63. doi: 10.2147/PGPM.S99634. eCollection 2016.

5.

Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.

Neřoldová M, Stránecký V, Hodaňová K, Hartmannová H, Piherová L, Přistoupilová A, Mrázová L, Vrablík M, Adámková V, Hubáček JA, Jirsa M, Kmoch S.

Pharmacogenomics. 2016 Aug;17(13):1405-14. doi: 10.2217/pgs-2016-0071. Epub 2016 Jun 14.

PMID:
27296017
6.

Cardiovascular Pharmacogenomics--Implications for Patients With CKD.

Cavallari LH, Mason DL.

Adv Chronic Kidney Dis. 2016 Mar;23(2):82-90. doi: 10.1053/j.ackd.2015.12.001. Review.

PMID:
26979147
7.
8.

The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy.

Eng H, Scialis RJ, Rotter CJ, Lin J, Lazzaro S, Varma MV, Di L, Feng B, West M, Kalgutkar AS.

Drug Metab Dispos. 2016 May;44(5):692-9. doi: 10.1124/dmd.115.067447. Epub 2016 Feb 17.

PMID:
26888941
9.

Statins and tendinopathy: a systematic review.

Teichtahl AJ, Brady SR, Urquhart DM, Wluka AE, Wang Y, Shaw JE, Cicuttini FM.

Med J Aust. 2016 Feb 15;204(3):115-21.e1. Review.

PMID:
26866552
10.

[Drug interaction in 63-year-old male sportsman--a case report].

Schetz D, Foerster J, Sein Anand J.

Przegl Lek. 2015;72(9):488-90. Polish.

PMID:
26827575
11.

Orbital myositis secondary to statin therapy.

Bahrami B, Rajak S, Selva D.

Med J Aust. 2015 Nov 2;203(9):365. No abstract available.

PMID:
26510805
12.

A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.

Whitehead NP, Kim MJ, Bible KL, Adams ME, Froehner SC.

Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12864-9. doi: 10.1073/pnas.1509536112. Epub 2015 Sep 28.

13.

Statin Lactonization by Uridine 5'-Diphospho-glucuronosyltransferases (UGTs).

Schirris TJ, Ritschel T, Bilos A, Smeitink JA, Russel FG.

Mol Pharm. 2015 Nov 2;12(11):4048-55. doi: 10.1021/acs.molpharmaceut.5b00474. Epub 2015 Oct 6.

PMID:
26412035
14.

Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control Studies.

Hou Q, Li S, Li L, Li Y, Sun X, Tian H.

Medicine (Baltimore). 2015 Sep;94(37):e1268. doi: 10.1097/MD.0000000000001268.

15.

Grapefruit Juice and Statins.

Lee JW, Morris JK, Wald NJ.

Am J Med. 2016 Jan;129(1):26-9. doi: 10.1016/j.amjmed.2015.07.036. Epub 2015 Aug 20. Review.

PMID:
26299317
16.

Effect of Low-Density Lipoprotein Cholesterol Lowering by Ezetimibe/Simvastatin on Outcome Incidence: Overview, Meta-Analyses, and Meta-Regression Analyses of Randomized Trials.

Thomopoulos C, Skalis G, Michalopoulou H, Tsioufis C, Makris T.

Clin Cardiol. 2015 Dec;38(12):763-9. doi: 10.1002/clc.22441. Epub 2015 Aug 18. Review.

17.

Colchicine toxicity in renal patients - Are we paying attention?

Medani S, Wall C.

Clin Nephrol. 2016 Aug;86(2):100-5. doi: 10.5414/CN108343.

PMID:
26249546
18.

Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials.

Banach M, Serban C, Ursoniu S, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Glasser SP, Watts GF, Blumenthal RS, Lip GY, Mikhailidis DP, Sahebkar A; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.

Pharmacol Res. 2015 Sep;99:329-36. doi: 10.1016/j.phrs.2015.07.008. Epub 2015 Jul 17.

PMID:
26192349
19.

From a fish tank injury to hospital haemodialysis: the serious consequences of drug interactions.

Hill FJ, McCloskey SJ, Sheerin N.

BMJ Case Rep. 2015 Jun 23;2015. pii: bcr2015209961. doi: 10.1136/bcr-2015-209961.

PMID:
26106178
20.

The effect of diabetes, hyperlipidemia, and statins on the development of rotator cuff disease: a nationwide, 11-year, longitudinal, population-based follow-up study.

Lin TT, Lin CH, Chang CL, Chi CH, Chang ST, Sheu WH.

Am J Sports Med. 2015 Sep;43(9):2126-32. doi: 10.1177/0363546515588173. Epub 2015 Jun 17.

PMID:
26085191
Items per page

Supplemental Content

Loading ...
Write to the Help Desk